the sun malaysia ipaper logo 150x150
Friday, July 3, 2026
27.5 C
Kuala Lumpur
the sun malaysia ipaper logo 150x150

F&B solutions provider Incite Innovations aims to go for IPO by 2025

PETALING JAYA: Incite Innovations Group, a food and beverage (F&B) solutions provider, aims to go for a listing on the stock exchange through an initial public offering (IPO) by 2025.

CEO Tham Lih Chung said the group is considering listing either the entire organisation or its subsidiary divisions separately.

“We have been looking at getting the company ready for listing. I will say hopefully in the next one to two years. I’ve given myself two years for the company to get listed,” he said in an interview with SunBiz.

Tham said Incite Innovations aims to capitalise on its rapid growth trajectory driven by fundraising efforts and investor support.

“I owe it to my shareholders. Why we are able to expand so fast? Mainly because we have raised some funds from Equity funding platform. We have about 300 shareholders with us,” he added.

Tham also shared insights into Incite Innovations’ revenue over the past few years.

In 2020, the company reported revenue of RM10 million. By 2023, this figure had risen 7.5-fold to RM75 million.

He said the primary sources driving revenue for the group are mainly from retail management solutions and retail technology solutions. This year, the group projected its revenue to be in the range of RM100 million to RM150 million.

“As of today, I can’t even categorise ourselves as a small enterprise. We have grown exponentially,” he said.

Tham remarked that Incite Innovations is already generating revenue from international markets.

However, the contribution from overseas income currently accounts for only 10% of the company’s total group revenue. Going forward, Tham aims to triple its international revenue contribution to 30% over the next three years.

“The end goal is for 50% of its total revenue to come from international markets, with the remaining 50% from domestic sources,“ he added.

STAY AHEAD OF THE CURVE

Join our community for instant updates and exclusive content.

Join Telegram Channel

Related


spot_img

Latest News

Addressing medical inflation

Consumers are struggling as medical insurance premiums surge, with over 340,000 dropping coverage amid calls for price regulation and stronger public healthcare

Bora Pharmaceuticals Completes Acquisition of MacroGenics’ Rockville Manufacturing Operations

TAIPEI, TAIWAN - Media OutReach Newswire - 2 July 2026 - Bora Pharmaceuticals Co., Ltd. ("Bora" or "Bora Group"; TWSE: 6472; OTCQX: BORAY) today announced the completion of its acquisition of the GMP manufacturing operations of MacroGenics, Inc. (NASDAQ: MGNX) including its biologics drug substance facility in Rockville, Maryland and an associated warehousing center in Frederick, Maryland, for total consideration of US $122.5 million through its wholly owned subsidiary Bora Biologics USA, LLC.. Upon closing, Bora signed a long-term CDMO Service Agreement with MacroGenics.

Most Viewed

spot_img
WC26

World Cup 2026

Updates, Fixtures, Results & Standings